MANIFOLD
Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?
9
Ṁ170Ṁ87
Aug 12
71%
chance

As implied in these tweets, among other places. Closes in 3 years.

Market context
Health
Medicine
Weight loss drugs
Get
Ṁ1,000
to start trading!
Sort by:

I think you only get a medical consensus with a randomised control trial, that takes time

People are also trading

Nobel Prize awarded for Ozempic (or GLP-1 drugs) by 2030?
-8% 1d38% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
86% chance
Will a study suggest GLP-1 agonists (and similar) have an effect on bulimia nervosa frequency or work as a treatment?
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
86% chance
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
55% chance
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
10% chance
Clinical trial shows by 2030 that GLP-1 receptor agonists significantly reduce osteoarthritis symptoms
68% chance
© Manifold Markets, Inc.•Terms•Privacy